Natantis shortlisted for Royal Society of Medicine's Innovation in Medicine Prize 2025

We’re excited to share that Natantis has been selected for an oral presentation by the Royal Society of Medicine as part of their Innovation in Medicine Prize.

This recognition highlights our team’s ongoing efforts to bring rapid, accessible cfDNA-based diagnostics closer to patient care.

Radhe Shantha Kumar will present recent findings from our initial clinical cohort, conducted in collaboration with the Malawi-Liverpool-Wellcome Trust and Heriot-Watt University, at the Tomorrow’s Doctors Conference, held at the Royal Society of Medicine in London on 19th July 2025.

We’re proud to see our work acknowledged for its translational potential and look forward to sharing how our technology continues to evolve to support early detection and management of infectious diseases. Stay tuned for more updates!